Alexander Rihane

First Berlin Equity Research

Recent Articles about Rakovina Therapeutics Inc.

Biotech Co. Has Promising AI-Accelerated Pipeline 04/07/2025

Rakovina Therapeutics Inc. (RKV:TSX.V) recently gained analyst coverage from First Berlin Equity Research. Read on to see why this company rates the stock a Buy.